Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Effects of AgRP inhibition on energy balance and metabolism in rodent models.

Dutia R, Kim AJ, Modes M, Rothlein R, Shen JM, Tian YE, Ihbais J, Victory SF, Valcarce C, Wardlaw SL.

PLoS One. 2013 Jun 6;8(6):e65317. doi: 10.1371/journal.pone.0065317. Print 2013.

2.

A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 1986. 137: 1270-1274.

Rothlein R, Dustin ML, Marlin SD, Springer TA.

J Immunol. 2011 May 1;186(9):5034-8. No abstract available.

3.

Induction by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986. 137: 245-254.

Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA.

J Immunol. 2011 May 1;186(9):5024-33. No abstract available.

4.

The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.

Schmidt AM, Sahagan B, Nelson RB, Selmer J, Rothlein R, Bell JM.

Curr Opin Investig Drugs. 2009 Jul;10(7):672-80. Review.

PMID:
19579173
5.

RAGE ligation affects T cell activation and controls T cell differentiation.

Chen Y, Akirav EM, Chen W, Henegariu O, Moser B, Desai D, Shen JM, Webster JC, Andrews RC, Mjalli AM, Rothlein R, Schmidt AM, Clynes R, Herold KC.

J Immunol. 2008 Sep 15;181(6):4272-8.

6.

Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study.

Eriksson BI, Dahl OE, Lassen MR, Ward DP, Rothlein R, Davis G, Turpie AG; Fixit Study Group.

J Thromb Haemost. 2008 Mar;6(3):457-63. Epub 2007 Dec 12.

7.

New class of orthopoxvirus antiviral drugs that block viral maturation.

Byrd CM, Bolken TC, Mjalli AM, Arimilli MN, Andrews RC, Rothlein R, Andrea T, Rao M, Owens KL, Hruby DE.

J Virol. 2004 Nov;78(22):12147-56.

8.

Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivatives.

Wu JP, Emeigh J, Gao DA, Goldberg DR, Kuzmich D, Miao C, Potocki I, Qian KC, Sorcek RJ, Jeanfavre DD, Kishimoto K, Mainolfi EA, Nabozny G Jr, Peng C, Reilly P, Rothlein R, Sellati RH, Woska JR Jr, Chen S, Gunn JA, O'Brien D, Norris SH, Kelly TA.

J Med Chem. 2004 Oct 21;47(22):5356-66.

PMID:
15481974
9.

Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assay.

Woska JR Jr, Last-Barney K, Rothlein R, Kroe RR, Reilly PL, Jeanfavre DD, Mainolfi EA, Kelly TA, Caviness GO, Fogal SE, Panzenbeck MJ, Kishimoto TK, Giblin PA.

J Immunol Methods. 2003 Jun 1;277(1-2):101-15.

PMID:
12799043
10.

Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study.

Furuya K, Takeda H, Azhar S, McCarron RM, Chen Y, Ruetzler CA, Wolcott KM, DeGraba TJ, Rothlein R, Hugli TE, del Zoppo GJ, Hallenbeck JM.

Stroke. 2001 Nov;32(11):2665-74.

PMID:
11692032
11.

Effects of anti-CD18 monoclonal antibody, R15.7, on the cardiopulmonary manifestations of group B streptococcal sepsis in piglets.

Bandel JW, Goldberg RN, Suguihara C, Nagoshi R, Martinez O, Rothlein R, Ruiz P, Bancalari E.

Biol Neonate. 2000;78(2):121-8.

PMID:
10971005
12.

Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades.

Hubbard AK, Rothlein R.

Free Radic Biol Med. 2000 May 1;28(9):1379-86. Review.

PMID:
10924857
13.

Neutrophils enhance clearance of necrotic epithelial cells in ozone-induced lung injury in rhesus monkeys.

Hyde DM, Miller LA, McDonald RJ, Stovall MY, Wong V, Pinkerton KE, Wegner CD, Rothlein R, Plopper CG.

Am J Physiol. 1999 Dec;277(6):L1190-8. doi: 10.1152/ajplung.1999.277.6.L1190.

PMID:
10600890
14.

Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesion.

Kelly TA, Jeanfavre DD, McNeil DW, Woska JR Jr, Reilly PL, Mainolfi EA, Kishimoto KM, Nabozny GH, Zinter R, Bormann BJ, Rothlein R.

J Immunol. 1999 Nov 15;163(10):5173-7.

15.

Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood.

Vuorte J, Lindsberg PJ, Kaste M, Meri S, Jansson SE, Rothlein R, Repo H.

J Immunol. 1999 Feb 15;162(4):2353-7.

16.

Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression.

Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, Williams JD, Topley N.

Kidney Int. 1998 Dec;54(6):2170-83.

17.

Molecular comparison of soluble intercellular adhesion molecule (sICAM)-1 and sICAM-3 binding to lymphocyte function-associated antigen-1.

Woska JR Jr, Morelock MM, Jeanfavre DD, Caviness GO, Bormann BJ, Rothlein R.

J Biol Chem. 1998 Feb 20;273(8):4725-33.

18.

Overview of leukocyte adhesion.

Rothlein R.

Neurology. 1997 Nov;49(5 Suppl 4):S3-4. Review. No abstract available.

PMID:
9371140
19.

Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism.

Christianson GJ, Brooks W, Vekasi S, Manolfi EA, Niles J, Roopenian SL, Roths JB, Rothlein R, Roopenian DC.

J Immunol. 1997 Nov 15;159(10):4781-92.

PMID:
9366402
20.

Inhibition of leucocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury.

Golino P, Ambrosio G, Ragni M, Cirillo P, Esposito N, Willerson JT, Rothlein R, Petrucci L, Condorelli M, Chiariello M, Buja LM.

Thromb Haemost. 1997 Apr;77(4):783-8.

PMID:
9134659
21.

Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease.

Haught WH, Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB, Hendricks C, Mehta JL.

Am Heart J. 1996 Jul;132(1 Pt 1):1-8.

PMID:
8701848
22.

Differential expression and release of CD54 induced by cytokines.

Mickelson JK, Kukielka G, Bravenec JS, Mainolfi E, Rothlein R, Hawkins HK, Kelly JH, Smith CW.

Hepatology. 1995 Sep;22(3):866-75.

PMID:
7657294
23.

The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1.

Reilly PL, Woska JR Jr, Jeanfavre DD, McNally E, Rothlein R, Bormann BJ.

J Immunol. 1995 Jul 15;155(2):529-32. Erratum in: J Immunol 1996 Apr 15;156(8):following 3088.

PMID:
7608533
24.
25.

Anti-ICAM in inflammatory disease.

Rothlein R.

Agents Actions Suppl. 1995;46:97-108. Review. No abstract available.

PMID:
7610995
26.

Treatment of inflammatory diseases with a monoclonal antibody to intercellular adhesion molecule 1.

Rothlein R, Jaeger JR.

Ciba Found Symp. 1995;189:200-8; discussion 208-11. Review.

PMID:
7587634
27.

Regulation of L-selectin expression by membrane proximal proteolysis.

Kishimoto TK, Kahn J, Migaki G, Mainolfi E, Shirley F, Ingraham R, Rothlein R.

Agents Actions Suppl. 1995;47:121-34.

PMID:
7540352
28.

Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.

Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, Peterson M.

Ann Neurol. 1995 Jan;37(1):55-62.

PMID:
7529475
29.

Mechanisms of polymorphonuclear leukocyte mediated peritoneal mesothelial cell injury.

Andreoli SP, Mallett C, Williams K, McAteer JA, Rothlein R, Doerschuk CM.

Kidney Int. 1994 Oct;46(4):1100-9.

30.

Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.

Zeng Y, Gage A, Montag A, Rothlein R, Thistlethwaite JR, Bluestone JA.

Transplantation. 1994 Sep 27;58(6):681-9.

PMID:
7940687
31.

Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival.

Ballantyne CM, Mainolfi EA, Young JB, Windsor NT, Cocanougher B, Lawrence EC, Pollack MS, Entman ML, Rothlein R.

J Heart Lung Transplant. 1994 Jul-Aug;13(4):597-603.

PMID:
7947875
32.

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1.

Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE.

Arthritis Rheum. 1994 Jul;37(7):992-9.

PMID:
7912930
33.

Isotype choice for chimeric antibodies affects binding properties.

Morelock MM, Rothlein R, Bright SM, Robinson MK, Graham ET, Sabo JP, Owens R, King DJ, Norris SH, Scher DS, et al.

J Biol Chem. 1994 Apr 29;269(17):13048-55.

34.

Cross-linking of ICAM-1 induces co-signaling of an oxidative burst from mononuclear leukocytes.

Rothlein R, Kishimoto TK, Mainolfi E.

J Immunol. 1994 Mar 1;152(5):2488-95.

PMID:
7510744
35.

Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites.

Kishimoto TK, Rothlein R.

Adv Pharmacol. 1994;25:117-69. Review. No abstract available.

PMID:
7515640
36.

Treatment of inflammation with anti-ICAM-1.

Rothlein R, Mainolfi EA, Kishimoto TK.

Res Immunol. 1993 Nov-Dec;144(9):735-9; discussion 754-62. Review. No abstract available.

PMID:
7909166
37.

Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.

Salafia CM, DeVore GR, Mainolfi E, Kelly J, Pezzullo JC, Rothlein R.

Am J Obstet Gynecol. 1993 Oct;169(4):830-4.

PMID:
7694462
38.

Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis.

Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE.

Arthritis Rheum. 1993 Aug;36(8):1098-102.

PMID:
8102057
39.

Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shock.

Eichacker PQ, Hoffman WD, Farese A, Danner RL, Suffredini AF, Waisman Y, Banks SM, Mouginis T, Wilson L, Rothlein R, et al.

J Appl Physiol (1985). 1993 Apr;74(4):1885-92.

PMID:
8099906
40.

Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke.

Clark WM, Coull BM, Briley DP, Mainolfi E, Rothlein R.

J Neuroimmunol. 1993 Apr;44(1):123-5.

PMID:
8098717
41.

A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients.

Haug CE, Colvin RB, Delmonico FL, Auchincloss H Jr, Tolkoff-Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmidt L, Cosimi AB.

Transplantation. 1993 Apr;55(4):766-72; discussion 772-3.

PMID:
8097341
42.
43.

Immuno-electron microscopic analysis of the distribution of ICAM-1 in human inflammatory tissue.

Brown KA, Perry ME, Mustapha Y, Rothlein R, Dumonde DC.

Agents Actions. 1993;38 Spec No:C35-8.

PMID:
8100384
44.
45.

Generation and characterization of an anti-idiotypic antibody specific for intercellular adhesion molecule-1.

Rothlein R, Kennedy C, Czajkowski M, Barton RW.

Int Arch Allergy Immunol. 1993;100(2):121-7.

PMID:
7680254
46.

Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM.

Lampeter ER, Kishimoto TK, Rothlein R, Mainolfi EA, Bertrams J, Kolb H, Martin S.

Diabetes. 1992 Dec;41(12):1668-71.

PMID:
1280239
47.

Elevated levels of cICAM-1 in patients with human T-cell leukemia virus type I associated myelopathy and adult T-cell leukemia.

Lal RB, Mainolfi E, Rothlein R.

Blood. 1992 Nov 1;80(9):2434-5. No abstract available.

PMID:
1358263
48.

Role of pulmonary phagocytes in host defense against group B streptococci in preterm versus term rabbit lung.

Sherman MP, Johnson JT, Rothlein R, Hughes BJ, Smith CW, Anderson DC.

J Infect Dis. 1992 Oct;166(4):818-26.

PMID:
1527417
49.

Adherent neutrophils mediate permeability after atelectasis.

Goldman G, Welbourn R, Rothlein R, Wiles M, Kobzik L, Valeri CR, Shepro D, Hechtman HB.

Ann Surg. 1992 Sep;216(3):372-8; discussion 378-80.

Supplemental Content

Loading ...
Support Center